URGN
UroGen Pharma Ltd.
$34.51
+$0.13(+0.36%)
58
Overall
40
Value
75
Tech
60
Quality
Market Cap
$1.71B
Volume
143.85K
52W Range
$6.64 - $32.37
Target Price
$36.88
Key Metrics Overview
| Market Cap | $1.71B | P/E Ratio | N/A |
| 52W High | $32.37 | 52W Low | $6.64 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 12.8% | 52W Position | 108.3% |
| Overall Score | 58 | Value Score | 40 |
| Quality Score | 60 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-0.98 | EPS Next Est | $1.4 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $34.51 | +0.4% | 143.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |